Evergreen Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $806K | Buy |
20,819
+10,803
| +108% | +$418K | 0.02% | 415 |
|
|
2025
Q1 | $392K | Sell |
10,016
-499
| -5% | -$19.5K | 0.01% | 601 |
|
|
2024
Q4 | $361K | Sell |
10,515
-1,282
| -11% | -$44K | 0.01% | 646 |
|
|
2024
Q3 | $487K | Sell |
11,797
-336
| -3% | -$13.9K | 0.02% | 511 |
|
|
2024
Q2 | $472K | Buy |
12,133
+564
| +5% | +$21.9K | 0.02% | 482 |
|
|
2024
Q1 | $501K | Buy |
11,569
+252
| +2% | +$10.9K | 0.02% | 448 |
|
|
2023
Q4 | $424K | Buy |
11,317
+522
| +5% | +$19.5K | 0.02% | 459 |
|
|
2023
Q3 | $395K | Buy |
10,795
+451
| +4% | +$16.5K | 0.02% | 451 |
|
|
2023
Q2 | $372K | Buy |
10,344
+1,444
| +16% | +$51.9K | 0.02% | 480 |
|
|
2023
Q1 | $320K | Buy |
8,900
+1,077
| +14% | +$38.7K | 0.01% | 487 |
|
|
2022
Q4 | $276K | Buy |
+7,823
| New | +$276K | 0.01% | 510 |
|
|
2022
Q3 | – | Sell |
-7,018
| Closed | -$384K | – | 624 |
|
|
2022
Q2 | $384K | Buy |
7,018
+1,544
| +28% | +$84.5K | 0.02% | 374 |
|
|
2022
Q1 | $298K | Buy |
5,474
+283
| +5% | +$15.4K | 0.01% | 480 |
|
|
2021
Q4 | $286K | Buy |
5,191
+264
| +5% | +$14.5K | 0.01% | 492 |
|
|
2021
Q3 | $235K | Buy |
4,927
+168
| +4% | +$8.01K | 0.01% | 499 |
|
|
2021
Q2 | $237K | Buy |
+4,759
| New | +$237K | 0.01% | 467 |
|
|
2020
Q1 | – | Sell |
-3,626
| Closed | -$213K | – | 422 |
|
|
2019
Q4 | $213K | Buy |
+3,626
| New | +$213K | 0.02% | 428 |
|
|
2018
Q2 | – | Sell |
-4,191
| Closed | -$205K | – | 381 |
|
|
2018
Q1 | $205K | Buy |
+4,191
| New | +$205K | 0.02% | 337 |
|